The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Israel-based Angioslide closed a $6.3 million Series C financing round led by TriVentures, a venture capital fund specializing in medical device technology investments, aimed at expanding its technology in the U.S.
Also participating in the round was return investor’s Viola Partners, Agate and XT Investments, according to the company.
MASSDEVICE ON CALL — A global healthcare payment model piloted in Massachusetts, largely considered a bellwether for national health system reform, was able to lower healthcare costs without sacrificing quality, according to a new study.
Called the Alternative Quality Contract, the alternative to the fee-for-service system is similar to the Affordable Care Act’s Accountable Care Organizations, Kaiser Health News reported.
Boston Scientific (NYSE:BSX) said the FDA approved the latest set of its pacemakers, including a device designed to treat patients who can’t regulate their heartbeats while exercising.
The Natick, Mass.-based med-tech maker said the watchdog agency granted pre-market approval for its Ingenio and Advantio pacemakers and for its Invive cardiac resynchronization therapy pacer.
